140 related articles for article (PubMed ID: 36573776)
1. Predictors of adherence to Narrowband ultraviolet B first-month treatment dosage plan.
Pavlotsky F; Alkhazov A; Barzilai A; Scope A
Isr Med Assoc J; 2022 Dec; 25(12):820-823. PubMed ID: 36573776
[TBL] [Abstract][Full Text] [Related]
2. Frequency of skin cancer among psoriasis, vitiligo, and mycosis fungoides patients treated with narrowband ultraviolet B phototherapy.
Mimouni I; Shulman J; Unes AA; Pavlovsky L; Pavlotsky F
Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12936. PubMed ID: 38059681
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of narrowband UVB phototherapy in early-stage mycosis fungoides in Iranian patients.
Shirzadian Kebria A; Asghari J; Tirgar Tabari S; Aryanian Z; Shirafkan H
Lasers Med Sci; 2022 Oct; 37(8):3231-3235. PubMed ID: 35838846
[TBL] [Abstract][Full Text] [Related]
4. Serum 25-hydroxyvitamin D increases with NB-UVB and UVA/UVB phototherapy in patients with psoriasis and atopic dermatitis in Western Australia.
Le P; Tu J; Gebauer K; Brown S
Australas J Dermatol; 2016 May; 57(2):115-21. PubMed ID: 25916422
[TBL] [Abstract][Full Text] [Related]
5. The impact of therapeutic modalities on patients with atopic dermatitis, psoriasis and vitiligo treated with phototherapy in the Jagiellonian University Outpatient Clinic.
Englert K; Kłosowicz A; Pelc P; Pastuszczak M; Wojas-Pelc A
Pol Merkur Lekarski; 2019 Mar; 46(273):125-129. PubMed ID: 30912521
[TBL] [Abstract][Full Text] [Related]
6. Risk of skin cancer in psoriasis patients receiving long-term narrowband ultraviolet phototherapy: Results from a Taiwanese population-based cohort study.
Lin TL; Wu CY; Chang YT; Juan CK; Chen CC; Yu SH; Chen YJ
Photodermatol Photoimmunol Photomed; 2019 May; 35(3):164-171. PubMed ID: 30536640
[TBL] [Abstract][Full Text] [Related]
7. A retrospective study of narrowband-UVB phototherapy for treatment of vitiligo in Malaysian patients.
Adauwiyah J; Suraiya HH
Med J Malaysia; 2010 Dec; 65(4):297-9. PubMed ID: 21901949
[TBL] [Abstract][Full Text] [Related]
8. Systematic review and estimated cost-efficacy of biologics compared with narrowband ultraviolet B light for the treatment of moderate to severe psoriasis and atopic dermatitis.
McCoy T; Natarelli N; Pan A; Shakhbazova A; Sivamani RK; Chambers CJ
Int J Dermatol; 2023 Aug; 62(8):986-999. PubMed ID: 37066447
[TBL] [Abstract][Full Text] [Related]
9. Potential of narrow-band ultraviolet B to induce sustained durable complete remission off-therapy in patients with stage I mycosis fungoides.
Pavlotsky F; Dawood M; Barzilai A
J Am Acad Dermatol; 2019 Jun; 80(6):1550-1555. PubMed ID: 29800582
[TBL] [Abstract][Full Text] [Related]
10. A large scale analytical study on efficacy of different photo(chemo)therapeutic modalities in the treatment of psoriasis, vitiligo and mycosis fungoides.
El-Mofty M; Mostafa WZ; Bosseila M; Youssef R; Esmat S; El Ramly A; Fawzi M; Mahgoub D; Nagui N; Mashaly HM; El-Fangary M; Fathy M
Dermatol Ther; 2010; 23(4):428-34. PubMed ID: 20666832
[TBL] [Abstract][Full Text] [Related]
11. Narrowband UVB phototherapy for early-stage mycosis fungoides: evaluation of clinical and histopathological changes.
Gökdemir G; Barutcuoglu B; Sakiz D; Köşlü A
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):804-9. PubMed ID: 16898902
[TBL] [Abstract][Full Text] [Related]
12. Narrowband UVB phototherapy in skin conditions beyond psoriasis.
Gambichler T; Breuckmann F; Boms S; Altmeyer P; Kreuter A
J Am Acad Dermatol; 2005 Apr; 52(4):660-70. PubMed ID: 15793518
[TBL] [Abstract][Full Text] [Related]
13. Treatment of moderate and severe adult chronic atopic dermatitis with narrow-band UVB and the combination of narrow-band UVB/UVA phototherapy.
Fernández-Guarino M; Aboin-Gonzalez S; Barchino L; Velazquez D; Arsuaga C; Lázaro P
Dermatol Ther; 2016; 29(1):19-23. PubMed ID: 26301893
[TBL] [Abstract][Full Text] [Related]
14. Ultraviolet phototherapy for cutaneous diseases: a concise review.
Vangipuram R; Feldman SR
Oral Dis; 2016 May; 22(4):253-9. PubMed ID: 26464123
[TBL] [Abstract][Full Text] [Related]
15. A retrospective, descriptive study of patients with Mycosis fungoides treated by phototherapy (oral PUVA, NB-UVB) with a twice-weekly regimen at the Institute of Dermatology, Bangkok, Thailand, with an experiential timeline of 13 years.
Pattamadilok B; Poomputsar T
Photodermatol Photoimmunol Photomed; 2021 Jan; 37(1):49-55. PubMed ID: 32964521
[TBL] [Abstract][Full Text] [Related]
16. An Update on Narrowband Ultraviolet B Therapy for the Treatment of Skin Diseases.
Myers E; Kheradmand S; Miller R
Cureus; 2021 Nov; 13(11):e19182. PubMed ID: 34873522
[TBL] [Abstract][Full Text] [Related]
17. Incidence of skin malignancies in patients with vitiligo or psoriasis who received narrowband ultraviolet B phototherapy (308 nm/311 nm): A retrospective review of 3730 patients.
Chia BKY; Yew YW; Zhao X; Chong WS; Thng TGS
Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):343-350. PubMed ID: 36345565
[TBL] [Abstract][Full Text] [Related]
18. Narrow-band ultraviolet B treatment for vitiligo, pruritus, and inflammatory dermatoses.
Samson Yashar S; Gielczyk R; Scherschun L; Lim HW
Photodermatol Photoimmunol Photomed; 2003 Aug; 19(4):164-8. PubMed ID: 12925186
[TBL] [Abstract][Full Text] [Related]
19. [Indications for UVB-phototherapy].
Schneider LA; Hinrichs R; Scharffetter-Kochanek K
Dtsch Med Wochenschr; 2007 Apr; 132(16):888-91. PubMed ID: 17443447
[No Abstract] [Full Text] [Related]
20. Narrow-band ultraviolet B phototherapy for early stage mycosis fungoides.
Xiao T; Xia LX; Yang ZH; He CD; Gao XH; Chen HD
Eur J Dermatol; 2008; 18(6):660-2. PubMed ID: 18955199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
